Wearable device aims to unfreeze gait in Parkinson's
NCT ID NCT07675408
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study tests whether a wearable device called cueStim can shorten the duration of freezing of gait—a sudden inability to move—in people with Parkinson's disease. About 60 participants, aged 60 to 90, will wear the device for four weeks during daily life and be assigned to one of two device modes. The goal is to see if one mode reduces freezing episodes better than the other.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cueStim wearable device
- What this could lead to
- If one mode works better, it could offer a non-drug way to reduce freezing-of-gait episodes and improve daily mobility for people with Parkinson's.
- What could go wrong
- This is an early comparison of two device modes, not a test against a placebo. It is small (60 people) and short (4 weeks), so results may not apply broadly or show clear benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE WITH FREEZING OF GAIT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arrow Clinical Trials
Daytona Beach, Florida, 32117, United States
-
Emory University
Atlanta, Georgia, 30329, United States
-
Evergreen Health Research Program
Kirkland, Washington, 98034, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida, 33486, United States
Contact Email: •••••@•••••
-
University of Kansas
Kansas City, Kansas, 66160, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.